Search

Objective: The aim of this study was to develop a method for discriminating between patients with Alzheimer disease (AD) and healthy subjects using layer analysis of cerebral blood flow (CBF) and xenon solubility coefficient (λ) in xenon-enhanced computed tomography (CT)., Methods: Xenon-enhanced CT was performed on 27 patients with AD (81.7 [3.3] years old) and 15 healthy volunteers (78.6 [4.0] years old) using a wide volume CT. For each subject, we created the first- (surface) to sixth-layer images of CBF and λ for the 6 viewing directions (layer thickness, 5 mm). For the discriminant views, receiver operating characteristic curves for the ratio of CBF to λ were created to identify patients with AD., Results: For the third- and fourth-layer left lateral views, which were designated as the discriminant views, areas under the receiver operating characteristic curve were 96.8% and 97.4%, respectively., Conclusions: With the use of the discriminant views obtained by xenon-enhanced CT, we could effectively discriminate between patients with AD and healthy subjects using both CBF and λ.

Objective: The purpose of this study was to clarify the difference between cerebral blood flow (CBF) by perfusion computed tomography (CT) and that by xenon-enhanced CT (Xe-CT) through simultaneous measurement., Methods: Xenon-enhanced CT and perfusion CT were continually performed on 7 normal subjects. Ratios of CBF by perfusion CT (P-CBF) to CBF by Xe-CT (Xe-CBF) were measured for 5 arterial territories; 3 were territories of 3 major arteries (the anterior [ACA], middle [MCA], and posterior [PCA] cerebral arteries), and the other 2 were areas of the thalamus and putamen., Results: The ratios were 1.30 +/- 0.10, 1.26 +/- 0.15, 1.61 +/- 0.15, 0.801 +/- 0.087, and 0.798 +/- 0.080 for the ACA, MCA, PCA, thalamus, and putamen, respectively. Although a good correlation was observed between P-CBF and Xe-CBF for each territory, the ratios were significantly different (P < 0.0001) between 3 territory groups (group 1: ACA and MCA, group 2: PCA, and group 3: thalamus and putamen)., Conclusions: The difference in the ratio of P-CBF to Xe-CBF between the 3 territory groups was considered to result principally from the features of P-CBF. To evaluate P-CBF properly, its territorial characteristics should be taken into account.

A noninvasive and quantitative technique has been developed to measure human hepatic blood flow by xenon computed tomography (Xe-CT). Accurate data on time-dependent xenon concentrations in the arterial blood are indispensable for Xe-CT to ensure quantitativeness of measured blood flow. A method has been established by our group to use both aorta and end-tidal data to obtain arterial xenon information. Multilevel (3 levels) maps of arterial blood flow (Fa), portal blood flow (Fp), and partition coefficient (lambda) were created for patients with chronic hepatitis. A method to objectively evaluate Fa, Fp, and lambda values for the whole liver has also been developed by our group.

The objective of this work is to propose a quantitative cerebral blood flow (CBF) calculation method for xenon CT (Xe-CT) by logically estimating the time course change rate (rate constant) of the arterial xenon concentration from that of end-tidal xenon concentration. A single factor, gamma (gamma), which is considered to reflect the diffusing capacity of the lung for xenon, was introduced to correlate the end-tidal rate constant (Kend-tidal) with the arterial rate constant (Karterial). When an appropriate value is given to gamma, it is possible to calculate the arterial rate constant (calculated Karterial) from Kend-tidal. A procedure was developed to determine the gamma value utilizing the characteristics of white matter lambda (lambda). This procedure was applied to three healthy volunteers. The gamma gammaalues for the three subjects were consistent with those directly calculated from end-tidal and arterial (abdominal aorta) xenon data. Hemispheric CBF values with use of calculated Karterial (47.3 +/- 10.3 ml/100 g/min) were close to the reported normative values. We conclude this method could make current Xe-CT examinations substantially reliable and quantitative in measuring CBF.

Purpose: The purpose of this work was to quantify arterial and portal blood flows in the human liver and to create blood flow maps by means of xenon CT., Method: Mathematical procedures were developed based on a simplified model having two tissue components: liver tissue and portal organ tissue. Xe-CT studies were performed on 10 healthy volunteers (ages 33.4 +/- 9.8 years), a patient with hepatocellular carcinoma (HCC), and a liver transplant recipient., Results: Arterial and portal blood flows for the healthy subjects were 36.7 +/- 5.2 and 65.2 +/- 22.0 ml/100 ml/min. In the HCC patient, arterial blood flow was shown to be dominant in the tumoral area. From the results of the liver recipient, it was demonstrated that obtaining lambda values is important for proper evaluation of blood flows., Conclusion: Xe-CT can provide substantial information on hepatic blood flow quantitatively and visually with separation of arterial and portal components.

Purpose: The purpose of this work is to show how variations in inhalation speed of xenon gas affect cerebral blood flow (CBF) values obtained using the end-tidal method on xenon-enhanced CT (Xe-CT). We tried to clarify whether arterial xenon concentration could keep up with end-tidal xenon concentration by evaluating the effect of xenon inhalation speed on calculated CBF values., Method: The same subject underwent two or three consecutive Xe-CT examinations, varying xenon inhalation speed. The rate constants of applied inhalation speeds were 0.1-0.15 min-1 (low speed), 0.25-0.3 min-1 (middle speed), and 1-2 min-1 (high speed), respectively., Results: No significant difference was observed among the CBF values of the same subject obtained under different inhalation speeds., Conclusion: End-tidal xenon can closely reflect arterial xenon under the customary method of xenon supply. The end-tidal method can provide reliable absolute CBF values, assuming actual CBF values are substantially unchanged regardless of the inhalation speed variation applied in this work.

Purpose: The goal of this work is to show how variations in respiratory rate and tidal volume affect calculated cerebral blood flow (CBF) values on xenon-enhanced CT. In xenon-enhanced CT examination, the patient often takes shallow and rapid breaths. Thus, it is less likely that end-tidal xenon concentration reflects arterial xenon concentration, and appropriate correction measures should be taken for the end-distal respiratory data to obtain reliable CBF values., Method: Preliminary breathing tests were performed using a lung phantom to determine the influence of respiratory volume and rate on end-tidal xenon concentration. Two xenon-enhanced CT studies were conducted of a healthy person with completely different respiratory manners between two studies. One was deep and slow respiration. The other was shallow and rapid respiration., Results: The lung phantom results prove that deep and slow respiration is essential for the end-tidal method. The results of xenon-enhanced CT studies of the same person show that the direct use of end-tidal data for shallow and rapid respiration leads to CBF values much lower than the actual values., Conclusion: Differences in respiratory rate and tidal volume during xenon inhalation can significantly affect calculated CBF values on xenon-enhanced CT. With use of the correction methods described herein, these effects can be minimized. We have derived the end-tidal correction method on the assumption that a person's CBF values should be kept unchanged regardless of different respiratory manners.